PDL BioPharma, Inc. Customer Advances, Current
PDL BioPharma, Inc. had Customer Advances, Current of $4.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Revenue Recognition and Deferred Revenue › ASU 2014-09 Transition
us-gaap:CustomerAdvancesCurrent · last filed 2019-05-09
- 2019-03-31: Customer Advances, Current $4.00K.
- 2018-12-31: Customer Advances, Current $1.00K.
- 2018-09-30: Customer Advances, Current $3.00K.
- 2018-06-30: Customer Advances, Current $0.00.
| Period end | Customer Advances, Current |
|---|---|
| 2019-03-31 | $4.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.00K 10-Q · filed 2019-05-09 |
| 2018-09-30 | $3.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 |
| 2018-03-31 | $415.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $3.20M 10-K · filed 2019-03-15 |
| 2017-09-30 | $13.47M 10-Q · filed 2017-11-13 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 |